Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000040947 | SCV000055122 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000040947 | SCV000064638 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Pro324Ser in Exon 07 of TTN: This variant is not expected to have clinical sig nificance because it has been identified in 1.1% (41/3738) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs72647845). |
Gene |
RCV001703918 | SCV000236753 | likely benign | not provided | 2020-10-01 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 23861362, 22863191) |
Ambry Genetics | RCV000249588 | SCV000318581 | benign | Cardiovascular phenotype | 2019-09-19 | criteria provided, single submitter | clinical testing | General population or subpopulation frequency is too high to be a pathogenic mutation based on disease/syndrome prevalence and penetrance |
Eurofins Ntd Llc |
RCV000040947 | SCV000342148 | benign | not specified | 2016-09-06 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000459552 | SCV000555655 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000040947 | SCV000616193 | benign | not specified | 2017-01-24 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000769142 | SCV000900516 | likely benign | Cardiomyopathy | 2017-03-16 | criteria provided, single submitter | clinical testing | |
Center for Advanced Laboratory Medicine, |
RCV000852946 | SCV000995692 | benign | Cardiomyopathy; Long QT syndrome | 2019-06-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040947 | SCV001432081 | likely benign | not specified | 2020-08-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839765 | SCV002101655 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839766 | SCV002101657 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839767 | SCV002101658 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839764 | SCV002101659 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000040947 | SCV001924829 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000040947 | SCV001975077 | benign | not specified | no assertion criteria provided | clinical testing |